Sign In
Buy OFIX
$9.72
+0.0100 (+0.103%)
At Close: Jun 03, 2026
Orthofix (OFIX) Secures FDA 510k Clearance for OsteoCove Graft
09:46am, Tuesday, 17'th Oct 2023
Orthofix (OFIX) announces the full commercial availability of the OsteoCove synthetic graft after gaining the FDA's nod.
Orthofix (OFIX) Soars 6.4%: Is Further Upside Left in the Stock?
09:46am, Friday, 13'th Oct 2023
Orthofix (OFIX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the ro
Why Shares of Orthofix Medical Are Plummeting on Tuesday
02:41pm, Tuesday, 12'th Sep 2023
All three fired executives came over late last year in the merger with SeaSpine. Chairman of the Board Catherine Burzik is stepping in as the interim CEO.
Orthofix terminates CEO, CFO and CLO for repeated ‘offensive conduct,' and stock plunges
07:16am, Tuesday, 12'th Sep 2023
Shares of Orthofix Medical Inc. OFIX, +1.42% plunged 17.1% toward a 10-month low in premarket trading Tuesday, after the spine and orthopedics company said it terminated Chief Executive Keith Valentin
Orthofix's (OFIX) New Launch to Benefit the MIS Spine Market
11:17am, Tuesday, 29'th Aug 2023
Orthofix (OFIX) announces the commercial launch and the successful completion of the first cases in the United States with the 7D FLASH Navigation System Percutaneous Module 2.0.
Orthofix: No Value-Creation Since SeaSpine Merger, Reiterate Hold
05:16am, Thursday, 22'nd Jun 2023
Orthofix Medical Inc.'s merger with SeaSpine has not significantly impacted investor sentiment or market expectations. Despite reasonable Q1 financial results, the lack of forecasted revenue growth an
Orthofix (OFIX) Advances in ALIF Procedure With New Launch
01:16pm, Tuesday, 20'th Jun 2023
Orthofix (OFIX) WaveForm A interbody features a wave-like design, providing a balance of strength, porosity and stability, along with a large implant graft aperture for bone graft material.
Orthofix Medical Inc. (OFIX) Q1 2023 Earnings Call Transcript
08:04am, Sunday, 14'th May 2023
Orthofix Medical Inc. (NASDAQ:OFIX ) Q1 2023 Results Conference Call May 9, 2023 4:30 PM ET Company Participants Alexa Huerta - Senior Director, Investor Relations Keith Valentine - President and Chie
Orthofix (OFIX) Reports Q1 Loss, Tops Revenue Estimates
06:20pm, Tuesday, 09'th May 2023
Orthofix (OFIX) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.10 per share a year ago.
Orthofix Medical Schedules First Quarter Earnings Release and Conference Call for May 9, 2023
04:01pm, Wednesday, 26'th Apr 2023
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its first quarter 2023 financial results o
Orthofix (OFIX) Q4 Earnings Beat Estimates, Gross Margin Dips
09:57am, Friday, 10'th Mar 2023
Orthofix (OFIX) reports impressive performance across the BGT and Global Orthopedics segment in the fourth quarter.
Orthofix Medical, Inc. (OFIX) Q4 2022 Earnings Call Transcript
07:10pm, Monday, 06'th Mar 2023
Orthofix Medical Inc. (NASDAQ:OFIX ) Q4 2022 Earnings Conference Call March 6, 2023 4:30 PM ET Company Participants Alexa Huerta - Senior Director, Investor Relations Keith Valentine - President and C
Orthofix Medical, Inc. (OFIX) Q3 2022 Earnings Call Transcript
10:42pm, Saturday, 05'th Nov 2022
Orthofix Medical, Inc. (NASDAQ:OFIX ) Q3 2022 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Alexa Huerta - Senior Director, IR Jon Serbousek - President, CEO & Director Dou
Orthofix (OFIX) Q3 Earnings and Revenues Surpass Estimates
09:48am, Thursday, 03'rd Nov 2022
Orthofix (OFIX) delivered earnings and revenue surprises of 550% and 2.70%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Orthofix (OFIX) Soars 5%: Is Further Upside Left in the Stock?
12:03pm, Friday, 14'th Oct 2022
Orthofix (OFIX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in
